India vaccinates more than 100 crore people Press Information Bureau Oct 22, 2021 More than 61lLakh doses administered in the last 24 hours
Centre provides over 97 crore COVID-19 vaccine doses to states and UTs Press Information Bureau Oct 12, 2021 Over 8.22 crore balance and unutilised vaccine doses still available with states and UTs
Health Minister launches ICMR’s drone-based vaccine delivery model Press Information Bureau Oct 5, 2021 This technology may prove a game changer in addressing the challenges in health care delivery, particularly health supplies in…
AYUSH Ministry paves way to strengthen Ayurveda and other traditional Indian medicine Press Information Bureau Sep 16, 2021 A Memorandum of Understanding (MoU) between the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) and…
Health Minister reviews availability of COVID-19 essential drugs Press Information Bureau Sep 2, 2021 Raw materials for the drugs are available in enough quantities
India’s first COVID-19 mRNA vaccine developed in partnership with DBT-BIRAC Press Information Bureau Aug 25, 2021 The Vaccine Subject Expert Committee (SEC) reviewed the interim phase-I data and found that HGCO19 was safe, tolerable and…
Centre provides over 57 crore vaccine doses to states and UTs Press Information Bureau Aug 23, 2021 Over 13 crore doses are in the pipeline
Cabinet approves MoU between ICMR and GARDP Foundation on AMR research and innovation Press Information Bureau Aug 19, 2021 The MoU will strengthen relations between India and Switzerland within the framework of international scientific and technological…
Delta Plus Variant is not yet classified as Variant of Concern: Dr VK Paul Press Information Bureau Jun 16, 2021 The way forward is to watch for its potential presence in the country and take the appropriate public health response, said Dr…
CSIR-CDRI, Lucknow sign license deal with Marc Labs to develop drug for treating heart attack,… Press Information Bureau Jun 11, 2021 The institute has recently obtained permission to initiate the Phase I clinical trials for the drug